Cargando…

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma

PURPOSE: The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination...

Descripción completa

Detalles Bibliográficos
Autores principales: Kluge, Regine, Chavdarova, Lidia, Hoffmann, Martha, Kobe, Carsten, Malkowski, Bogdan, Montravers, Françoise, Kurch, Lars, Georgi, Thomas, Dietlein, Markus, Wallace, W. Hamish, Karlen, Jonas, Fernández-Teijeiro, Ana, Cepelova, Michaela, Wilson, Lorrain, Bergstraesser, Eva, Sabri, Osama, Mauz-Körholz, Christine, Körholz, Dieter, Hasenclever, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786307/
https://www.ncbi.nlm.nih.gov/pubmed/26963909
http://dx.doi.org/10.1371/journal.pone.0149072
_version_ 1782420535264673792
author Kluge, Regine
Chavdarova, Lidia
Hoffmann, Martha
Kobe, Carsten
Malkowski, Bogdan
Montravers, Françoise
Kurch, Lars
Georgi, Thomas
Dietlein, Markus
Wallace, W. Hamish
Karlen, Jonas
Fernández-Teijeiro, Ana
Cepelova, Michaela
Wilson, Lorrain
Bergstraesser, Eva
Sabri, Osama
Mauz-Körholz, Christine
Körholz, Dieter
Hasenclever, Dirk
author_facet Kluge, Regine
Chavdarova, Lidia
Hoffmann, Martha
Kobe, Carsten
Malkowski, Bogdan
Montravers, Françoise
Kurch, Lars
Georgi, Thomas
Dietlein, Markus
Wallace, W. Hamish
Karlen, Jonas
Fernández-Teijeiro, Ana
Cepelova, Michaela
Wilson, Lorrain
Bergstraesser, Eva
Sabri, Osama
Mauz-Körholz, Christine
Körholz, Dieter
Hasenclever, Dirk
author_sort Kluge, Regine
collection PubMed
description PURPOSE: The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination between score D1,2,3 and score D4,5. Inter-reader reliability of the whole scale is not well characterised. METHODS: Five international expert readers scored 100 interim PET/CT scans from paediatric HL patients. Scans were acquired in 51 European hospitals after two courses of OEPA chemotherapy (according to the EuroNet-PHL-C1 study). Images were interpreted in direct comparison with staging PET/CTs. RESULTS: The probability that two random readers concord on the five point D score of a random case is only 42% (global kappa = 0.24). Aggregating to a three point scale D1,2 vs. D3 vs. D4,5 improves concordance to 60% (kappa = 0.34). Concordance if one of two readers assigns a given score is 70% for score D1,2 only 36% for score D3 and 64% for D4,5. Concordance for the binary decisions D1,2 vs. D3,4,5 is 67% and 86% for D1,2,3 vs D4,5 (kappa = 0.36 resp. 0.56). If one reader assigns D1,2,3 concordance probability is 92%, but only 64% if D4,5 is called. Discrepancies occur mainly in mediastinum, neck and skeleton. CONCLUSION: Inter-reader reliability of the five point D-scale is poor in this interobserver analysis of paediatric patients who underwent OEPA. Inter-reader variability is maximal in cases assigned to D2 or D3. The binary distinction D1,2,3 versus D4,5 is the most reliable criterion for clinical decision making.
format Online
Article
Text
id pubmed-4786307
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47863072016-03-23 Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma Kluge, Regine Chavdarova, Lidia Hoffmann, Martha Kobe, Carsten Malkowski, Bogdan Montravers, Françoise Kurch, Lars Georgi, Thomas Dietlein, Markus Wallace, W. Hamish Karlen, Jonas Fernández-Teijeiro, Ana Cepelova, Michaela Wilson, Lorrain Bergstraesser, Eva Sabri, Osama Mauz-Körholz, Christine Körholz, Dieter Hasenclever, Dirk PLoS One Research Article PURPOSE: The five point Deauville (D) scale is widely used to assess interim PET metabolic response to chemotherapy in Hodgkin lymphoma (HL) patients. An International Validation Study reported good concordance among reviewers in ABVD treated advanced stage HL patients for the binary discrimination between score D1,2,3 and score D4,5. Inter-reader reliability of the whole scale is not well characterised. METHODS: Five international expert readers scored 100 interim PET/CT scans from paediatric HL patients. Scans were acquired in 51 European hospitals after two courses of OEPA chemotherapy (according to the EuroNet-PHL-C1 study). Images were interpreted in direct comparison with staging PET/CTs. RESULTS: The probability that two random readers concord on the five point D score of a random case is only 42% (global kappa = 0.24). Aggregating to a three point scale D1,2 vs. D3 vs. D4,5 improves concordance to 60% (kappa = 0.34). Concordance if one of two readers assigns a given score is 70% for score D1,2 only 36% for score D3 and 64% for D4,5. Concordance for the binary decisions D1,2 vs. D3,4,5 is 67% and 86% for D1,2,3 vs D4,5 (kappa = 0.36 resp. 0.56). If one reader assigns D1,2,3 concordance probability is 92%, but only 64% if D4,5 is called. Discrepancies occur mainly in mediastinum, neck and skeleton. CONCLUSION: Inter-reader reliability of the five point D-scale is poor in this interobserver analysis of paediatric patients who underwent OEPA. Inter-reader variability is maximal in cases assigned to D2 or D3. The binary distinction D1,2,3 versus D4,5 is the most reliable criterion for clinical decision making. Public Library of Science 2016-03-10 /pmc/articles/PMC4786307/ /pubmed/26963909 http://dx.doi.org/10.1371/journal.pone.0149072 Text en © 2016 Kluge et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kluge, Regine
Chavdarova, Lidia
Hoffmann, Martha
Kobe, Carsten
Malkowski, Bogdan
Montravers, Françoise
Kurch, Lars
Georgi, Thomas
Dietlein, Markus
Wallace, W. Hamish
Karlen, Jonas
Fernández-Teijeiro, Ana
Cepelova, Michaela
Wilson, Lorrain
Bergstraesser, Eva
Sabri, Osama
Mauz-Körholz, Christine
Körholz, Dieter
Hasenclever, Dirk
Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
title Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
title_full Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
title_fullStr Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
title_full_unstemmed Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
title_short Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma
title_sort inter-reader reliability of early fdg-pet/ct response assessment using the deauville scale after 2 cycles of intensive chemotherapy (oepa) in hodgkin’s lymphoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786307/
https://www.ncbi.nlm.nih.gov/pubmed/26963909
http://dx.doi.org/10.1371/journal.pone.0149072
work_keys_str_mv AT klugeregine interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT chavdarovalidia interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT hoffmannmartha interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT kobecarsten interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT malkowskibogdan interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT montraversfrancoise interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT kurchlars interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT georgithomas interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT dietleinmarkus interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT wallacewhamish interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT karlenjonas interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT fernandezteijeiroana interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT cepelovamichaela interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT wilsonlorrain interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT bergstraessereva interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT sabriosama interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT mauzkorholzchristine interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT korholzdieter interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma
AT hasencleverdirk interreaderreliabilityofearlyfdgpetctresponseassessmentusingthedeauvillescaleafter2cyclesofintensivechemotherapyoepainhodgkinslymphoma